openPR Logo
Press release

Hypersensitivity Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results

04-09-2019 02:29 PM CET | Health & Medicine

Press release from: Pharma Proff

Hypersensitivity Therapeutics - Pipeline Analysis 2018,

Hypersensitivity is a group of undesirable reactions that are produced by normal immune systems, due to allergies and autoimmune disorders in body. These are considered as an over-reaction by the immune system and can be damaging, uncomfortable, or occasionally incurable.

Download the sample report @ https://www.pharmaproff.com/request-sample/1049

Hypersensitivity is also defined as an abnormal or pathologic immune reaction that is caused by an immune response to repeated exposure to an antigen. It is categorized into different types; type I, type II, type III, type IV, and type V. According to the data published by the American Academy of Allergy Asthma and Immunology, 10.6% or 7.8 million children in the U.S. reported respiratory allergies in 2012.

Get the detailed analysis @ https://www.pharmaproff.com/report/hypersensitivity-therapeutics-pipeline-analysis

HAL Allergy Group is in the process of developing HAL-MPE1 for the treatment of hypersensitivity and renal toxicity. Some of the companies having a pipeline of hypersensitivity include Pulmatrix Inc. and NeRRe Therapeutics.

Make enquiry before purchase @ https://www.pharmaproff.com/enquiry/1049

• The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.
• Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

About Us:
Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.

Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com
Web: https://www.pharmaproff.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hypersensitivity Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results here

News-ID: 1695615 • Views: 265

More Releases from Pharma Proff

Interleukin-6 (IL-6) Inhibitors Analysis, Clinical Trails and Developments
Interleukin-6 (IL-6) inhibitors currently exhibit a proliferating pipeline with 25+ therapeutic candidates. IL-6 is a cytokine encoded by IL-6 gene, which helps in the maturation of B cells and is actively involved in the inflammatory response. The IL-6 protein is primarily produced at the sites of acute and chronic inflammation, where it is secreted into the serum and brings a transcriptional inflammatory response through IL-6? receptor. This protein is assumed to
Retinitis Pigmentosa Therapeutics Analysis, Clinical Trials and Other Developmen …
Retinitis pigmentosa therapeutics currently exhibits a proliferating pipeline with 25+ therapeutic candidates. Retinitis pigmentosa (RP) is a group of hereditary disorders that lead to the breakdown and loss of cells in the retina. Mutation in genes encoding the proteins required by retinal cells for their proper functioning, results in occurrence of RP. The disease results in partial vision loss during the earlier stage of the disease, which may lead to complete
Probiotics Therapeutics -Pipeline Analysis 2018, Clinical Trials & Results, Pate …
Probiotics are live microorganisms that produces beneficial effects in human gut. Probiotics can be taken as a dietary supplement. They prevent diarrhoea and help to reduce the symptoms of irritable bowel syndrome. Download the sample report at: https://www.pharmaproff.com/request-sample/1189 Probiotics comprise of a variety of microorganisms belonging to the Lactobacillus and Bifidobacterium groups. The only yeast probiotic that has proven to be effective is Saccharomyces boulardii. According to researchers, probiotics are effective in
Niemann-Pick Disease Type C (NPC) Therapeutics Pipeline to Witness Significant G …
Niemann-Pick disease is divided into four main types: type A, type B, type C1, and type C2. These types are classified on the basis of genetic cause and signs and symptoms of the disease. NPC is identified as a rare genetic disorder in which the body is unable to transport cholesterol and lipids inside the cells. This causes accumulation of these substances within various tissues of the body. These substances

All 5 Releases


More Releases for Hypersensitivity

Cough Hypersensitivity Syndrome Treatment Market Trends by Manufacturers, States …
Transparency Market Research (TMR) has published a new report on the cough hypersensitivity syndrome treatment market for the forecast period of 2019–2027. According to the report, the global cough hypersensitivity syndrome treatment market was valued at ~US$ 7 Bn in 2018, and is projected to expand at a CAGR of 5.5% from 2019 to 2027. Cough hypersensitivity syndrome encompasses various cough-related conditions arising from exposure to certain mechanical, thermal, and chemical
Hypersensitivity Pneumonitis Market Expert Financial Overview | Success Mileston …
World Hypersensitivity Pneumonitis Market report titled “Hypersensitivity Pneumonitis Market Research Report – Forecast to 2023” is an expert analysis report explores the market by Research Methodology, Segmentation, Key Players, Major Region in-depth. Hypersensitivity Pneumonitis Market -Scenario Hypersensitivity pneumonitis is a complex syndrome caused due to exposure to a variety of organic particles. Hypersensitivity pneumonitis is divided into three types, acute hypersensitivity pneumonitis, subacute hypersensitivity pneumonitis, and chronic hypersensitivity pneumonitis which is based
Hypersensitivity Pneumonitis Market Expert Financial Overview | Success Mileston …
Hypersensitivity Pneumonitis Market Research Report, By Type (Acute, Subacute, Chronic), By Therapy (Diagnosis (Chest Lung Function Tests, X-Ray, Lung Biopsy) Treatment (Pharmacological (Corticosteroid))), End User (Hospital) - Global Forecast till 2023 Market Scenario: Hypersensitivity pneumonitis is a complex syndrome caused due to exposure to a variety of organic particles. Hypersensitivity pneumonitis is divided into three types, acute hypersensitivity pneumonitis, subacute hypersensitivity pneumonitis, and chronic hypersensitivity pneumonitis which is based on the
Hypersensitivity Market Scope and Opportunities Analysis 2014 – 2020
Hypersensitivity reaction is the over reactive immunological response towards antigens. In some cases, body’s own cells are miss-read as foreign cells and immune response is mounted against these cells. Hypersensitivity may lead to serious injuries, lifelong disorders and even death. There are two types of hypersensitivity reactions, namely, immediate hypersensitivity reaction and delayed hypersensitivity. Immediate reaction also called as allergic reactions involve antibodies while delayed type reactions involve T lymphocytes.
Hypersensitivity Market to Reflect Impressive Growth Rate by 2020
Hypersensitivity reaction is the over reactive immunological response towards antigens. In some cases, body’s own cells are miss-read as foreign cells and immune response is mounted against these cells. Hypersensitivity may lead to serious injuries, lifelong disorders and even death. There are two types of hypersensitivity reactions, namely, immediate hypersensitivity reaction and delayed hypersensitivity. Immediate reaction also called as allergic reactions involve antibodies while delayed type reactions involve T lymphocytes.
Global Hypersensitivity Market Estimated to Expand at a Robust CAGR over 2014 …
Hypersensitivity reaction is the over reactive immunological response towards antigens. In some cases, body’s own cells are miss-read as foreign cells and immune response is mounted against these cells. Hypersensitivity may lead to serious injuries, lifelong disorders and even death. There are two types of hypersensitivity reactions, namely, immediate hypersensitivity reaction and delayed hypersensitivity. Immediate reaction also called as allergic reactions involve antibodies while delayed type reactions involve T lymphocytes.